Järnerot G
Acta Med Scand. 1975 Jan-Feb;197(1-2):77-81. doi: 10.1111/j.0954-6820.1975.tb04881.x.
In order to investigate the prevalence of iodine depletion in chronic inflammatory bowel disease two separate studies have been performed. One was devoted to the 24-hour urinary iodine excretion and 50 patients with ulcerative colitis or Crohn's disease were examined and compared with 102 controls. In the other study the thyroid 131I uptake was compared in 38 patients and 36 controls. Ten of the 50 patients with chronic inflammatory bowel disease had a 24-hour urinary iodine excretion less than 40 mug, compared with 5 of the 102 controls (p greater than 0.01). Sixteen of the 38 patients had a 24-hour thyroid 131I uptake of 50% or more of the administered test does, compared with 4 of the 36 controls (p smaller than 0.01). These results are compatible with an increased occurrence of iodine deficiency in patients with chronic inflammatory bowel disease. Treatment with corticosteroids or Salazopyrin or a milk-free diet did not influence these findings. No evidence was found of an impaired absorption of inorganic iodide from the gut.?31
为了调查慢性炎症性肠病中碘缺乏的患病率,已开展了两项独立研究。一项研究关注24小时尿碘排泄情况,对50例溃疡性结肠炎或克罗恩病患者进行了检查,并与102名对照者进行比较。在另一项研究中,对38例患者和36名对照者的甲状腺131I摄取情况进行了比较。50例慢性炎症性肠病患者中有10例24小时尿碘排泄低于40微克,而102名对照者中有5例(p>0.01)。38例患者中有16例24小时甲状腺131I摄取量为给予试验剂量的50%或更多,而36名对照者中有4例(p<0.01)。这些结果与慢性炎症性肠病患者碘缺乏发生率增加相符。使用皮质类固醇、柳氮磺胺吡啶治疗或无奶饮食并未影响这些结果。未发现肠道对无机碘吸收受损的证据。